Dexcom (DXCM) EPS (Diluted) Growth (3y) (2016 - 2026)
Dexcom (DXCM) EPS (Diluted) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | -12.16% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 19.81% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 50.83% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | -6.12% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 33.46% |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 11.48% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1,810.75% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 18.07% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 1.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.46% |
| Mar 31, 2026 | 63.42% |
| Dec 31, 2025 | 45.33% |
| Sep 30, 2025 | 43.11% |
| Jun 30, 2025 | 53.92% |
| Mar 31, 2025 | 4.46% |
| Dec 31, 2024 | 209.93% |
| Sep 30, 2024 | 14.75% |
| Jun 30, 2024 | 20.50% |
| Mar 31, 2024 | 35.22% |
| Dec 31, 2023 | -17.03% |
| Sep 30, 2023 | 15.95% |
| Jun 30, 2023 | 31.05% |
| Mar 31, 2023 | 29.99% |
| Dec 31, 2022 | -5.08% |
| Sep 30, 2022 | 24.29% |
| Jun 30, 2022 | 83.63% |
| Mar 31, 2022 | 71.53% |
| Dec 31, 2021 | 70.38% |
| Sep 30, 2021 | 18.96% |